13D/13G Filings - Salarius Pharmaceuticals Inc. (SLRX)

Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Reported
DateTime		Transaction
Date		TypeCompany
Symbol		Filed By
Symbol		Shares Owned
% Owned		Shares Vs. Prev ReportView
2024-11-14
4:38 pm
Purchase		2024-09-3013GSalarius Pharmaceuticals, Inc.
SLRX		ARMISTICE CAPITAL LLC75,690
4.990%		75,690increase
(New Position)		Filing
History
2024-02-14
3:54 pm
Purchase		2023-12-3113GSalarius Pharmaceuticals, Inc.
SLRX		ARMISTICE CAPITAL LLC53,419
9.990%		53,419increase
(New Position)		Filing
History
2023-10-27
3:57 pm
Purchase		2023-10-2313DSalarius Pharmaceuticals, Inc.
SLRX		Lee Elvin Sanghwan25,534
6.090%		25,534increase
(New Position)		Filing
History
2023-02-13
4:30 pm
Purchase		2022-12-3113GSalarius Pharmaceuticals, Inc.
SLRX		Lind Global Fund II LP11,137
3.800%		11,137increase
(New Position)		Filing
History
2022-04-29
4:31 pm
Purchase		2022-04-2613GSalarius Pharmaceuticals, Inc.
SLRX		Lind Global Fund II LP14,849
5.300%		14,849increase
(New Position)		Filing
History
2022-04-27
10:52 am
Purchase		2022-04-2213GSalarius Pharmaceuticals, Inc.
SLRX		Lincoln Park Capital Fund LLC14,849
5.980%		14,849increase
(New Position)		Filing
History
2022-02-10
4:05 pm
Sale		2021-12-3113GSalarius Pharmaceuticals, Inc.
SLRX		Sio Capital Management LLC6,771
3.000%		-1,515decrease
(-18.28%)		Filing
History
2021-02-16
1:03 pm
Purchase		2020-12-3113GSalarius Pharmaceuticals, Inc.
SLRX		Sio Capital Management LLC8,286
8.350%		8,286increase
(New Position)		Filing
History
2021-02-16
10:07 am
Unchanged		2020-12-3113GSalarius Pharmaceuticals, Inc.
SLRX		CVI Investments, Inc.4,022
4.100%		0
(Unchanged)		Filing
History
2021-02-11
7:15 pm
Sale		2021-01-0413GSalarius Pharmaceuticals, Inc.
SLRX		Orin Hirschman5,833
4.990%		-254decrease
(-4.17%)		Filing
History
2021-01-28
2:25 pm
Sale		2020-12-3113GSalarius Pharmaceuticals, Inc.
SLRX		Empery Asset Management, LP4,022
3.900%		-2,228decrease
(-35.65%)		Filing
History
2020-08-04
09:18 am
Purchase		2020-07-3013GSalarius Pharmaceuticals, Inc.
SLRX		Empery Asset Management, LP6,250
6.900%		6,250increase
(New Position)		Filing
History
2020-02-20
5:39 pm
Sale		2020-02-1113DSalarius Pharmaceuticals, Inc.
SLRX		Sharma Sunil1,173
1.820%		-564decrease
(-32.47%)		Filing
History
2020-02-20
5:35 pm
Purchase		2020-02-1113DSalarius Pharmaceuticals, Inc.
SLRX		Northrup Jonathan P1,822
2.830%		102increase
(+5.93%)		Filing
History
2020-02-18
08:00 am
Purchase		2020-02-1113GSalarius Pharmaceuticals, Inc.
SLRX		Mitchell P. Kopin3,306
4.990%		3,306increase
(New Position)		Filing
History
2020-02-14
2:48 pm
Purchase		2020-02-0713GSalarius Pharmaceuticals, Inc.
SLRX		ARMISTICE CAPITAL LLC3,174
4.990%		3,174increase
(New Position)		Filing
History
2020-02-14
08:58 am
Purchase		2020-02-0713GSalarius Pharmaceuticals, Inc.
SLRX		CVI Investments, Inc.4,022
6.900%		4,022increase
(New Position)		Filing
History
2020-02-13
3:16 pm
Purchase		2020-02-0713GSalarius Pharmaceuticals, Inc.
SLRX		Orin Hirschman6,087
9.470%		6,087increase
(New Position)		Filing
History
2020-02-12
6:58 pm
Purchase		2019-12-3113GSalarius Pharmaceuticals, Inc.
SLRX		Renaissance Technologies LLC294
1.450%		294increase
(New Position)		Filing
History